MWG Biotech in Distribution Deal | GenomeWeb

 

NEW YORK, Aug. 6 (GenomeWeb News) – MWG Biotech said today that it has signed a five-year distribution agreement with the Austrian company HVD.

Financial details were not provided.

HVD is a global marketing and distribution company that specializes in life sciences products. The exclusive distribution agreement covers South America, Eastern Europe, Middle East, Africa and the independent countries of the former Soviet Union.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.